top of page
-
Blood Borne VirusesHepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
-
Enteric Viruses and BacteriaClostridium difficile EHEC Norovirus Rotavirus
-
Human Adenovirus, Human Herpesvirus and PolyomavirusHuman adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
-
Respiratory Viruses, Bacteria and FungiHuman adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
-
Tropical and other Viruses, Bacteria and ParasitesAHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
Blood Borne Virus EQA Programme
-
B19 virus DNA
-
HBV Drug Resistance Typing
-
HCV Drug Resistance Typing
-
HIV Drug Resistance
-
HIV-1 DNA
-
Hepatitis A virus RNA
-
Hepatitis B Virus DNA
-
Hepatitis C Virus RNA
-
Hepatitis D Virus
-
Hepatitis E virus RNA
-
Human Immunodeficiency Virus RNA
-
Human Immunodeficiency Virus Type 2
The Bloodborne Virus (BBV) group of QCMD External Quality Assessment (EQA) schemes consist of pathogens that are detected from the blood. This includes human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) B19 virus (B19) and more recently hepatitis A virus (HAV), hepatitis E virus (HEV) and hepatitis D virus (HDV).
bottom of page